Dogwood Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Dogwood Therapeutics Current Ratio Growth & History (DWTX)
Dogwood Therapeutics's current ratio was 2.76 for fiscal 2025.
View full Dogwood Therapeutics company overviewDogwood Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.76 | −2.45 | −47.09% |
| 2024 | 2024-12-31 | 5.21 | −6.41 | −55.17% |
| 2023 | 2023-12-31 | 11.62 | 3.59 | +44.81% |
| 2022 | 2022-12-31 | 8.02 | −4.35 | −35.13% |
| 2021 | 2021-12-31 | 12.37 | −8.18 | −39.80% |
| 2020 | 2020-12-31 | 20.55 | — | — |
Dogwood Therapeutics quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 3.89 | −3.91 | −50.07% |
| Q1 2026 | 2026-03-31 | 5.86 | −1.57 | −21.10% |
| Q4 2025 | 2025-12-31 | 2.76 | −2.45 | −47.09% |
| Q3 2025 | 2025-09-30 | 4.49 | 2.78 | +162.20% |
| Q2 2025 | 2025-06-30 | 7.80 | 0.53 | +7.28% |
| Q1 2025 | 2025-03-31 | 7.43 | 1.77 | +31.33% |
| Q4 2024 | 2024-12-31 | 5.21 | −6.41 | −55.17% |
| Q3 2024 | 2024-09-30 | 1.71 | −9.06 | −84.11% |
| Q2 2024 | 2024-06-30 | 7.27 | −2.75 | −27.46% |
| Q1 2024 | 2024-03-31 | 5.66 | −6.21 | −52.35% |
| Q4 2023 | 2023-12-31 | 11.62 | 3.59 | +44.81% |
| Q3 2023 | 2023-09-30 | 10.77 | 4.13 | +62.06% |
| Q2 2023 | 2023-06-30 | 10.02 | 5.26 | +110.40% |
| Q1 2023 | 2023-03-31 | 11.87 | 5.19 | +77.57% |
| Q4 2022 | 2022-12-31 | 8.02 | −4.35 | −35.13% |
| Q3 2022 | 2022-09-30 | 6.65 | −9.74 | −59.44% |
| Q2 2022 | 2022-06-30 | 4.76 | −21.46 | −81.83% |
| Q1 2022 | 2022-03-31 | 6.69 | −17.54 | −72.40% |
| Q4 2021 | 2021-12-31 | 12.37 | −8.18 | −39.80% |
| Q3 2021 | 2021-09-30 | 16.39 | — | — |
| Q2 2021 | 2021-06-30 | 26.22 | — | — |
| Q1 2021 | 2021-03-31 | 24.22 | — | — |
| Q4 2020 | 2020-12-31 | 20.55 | — | — |
Dogwood Therapeutics current ratio trends
Over the last five fiscal years, Dogwood Therapeutics's current ratio decreased from 20.55 to 2.76, a change of −17.79. The latest reported quarter, Q2 2026, shows 3.89.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dogwood Therapeutics source filings ↗